Construction and Validation of a Protocol Targeting Patients on Oral Anticoagulation with Warfarin
- PMID: 37403872
- PMCID: PMC10344350
- DOI: 10.36660/abc.20220576
Construction and Validation of a Protocol Targeting Patients on Oral Anticoagulation with Warfarin
Erratum in
-
Erratum.Arq Bras Cardiol. 2023 Dec;120(12):e20230806. doi: 10.36660/abc.20230806. Arq Bras Cardiol. 2023. PMID: 38232247 Free PMC article. English, Portuguese.
Abstract
Background: Warfarin is an oral anticoagulant that is very useful in preventing thromboembolism, though it is considered a drug with a high risk of causing adverse events. Considering the practical challenges in controlling oral anticoagulation, the patients on warfarin could benefit from educational strategies aimed at behavioral changes, active participation in self-care, and adherence to drug therapy.
Objective: The aim was to construct and validate the EmpoderACO protocol for behavioral changes in warfarin patients.
Methods: The methodological steps were: definition of concepts and domains of self-care, identification of objectives, construction and selection of items, assessment of content validity, and pre-test in the target population.
Results: Relevance, adequacy, clarity, and internal reliability of the instrument's items were assessed by a multidisciplinary judges committee (JC) through the E-surv web platform, obtaining an average agreement of ≥0.91. The understanding of the instrument measured by the target population revealed adequate clarity with a coefficient average of 0.96.
Conclusion: EmpoderACO can aid in qualifying the communication process between medical professionals and patients, as well as in improving adherence to both treatment and clinical outcomes, and can be replicated in healthcare settings.
Fundamento: A varfarina é um anticoagulante oral útil para prevenção de tromboembolismo, embora seja considerado fármaco de alto risco de causar eventos adversos. Considerando os desafios práticos no controle da anticoagulação oral, os pacientes poderiam se beneficiar de estratégias educacionais que visem mudança de comportamento, participação ativa no autocuidado e adesão à farmacoterapia.
Objetivo: Construir e validar o protocolo EmpoderACO para mudança de comportamento em pacientes em uso de varfarina.
Métodos: As etapas metodológicas foram: definição de conceitos e domínios do autocuidado, identificação dos objetivos, construção e seleção dos itens, avaliação da validade de conteúdo e pré-teste na população alvo.
Resultados: Relevância, adequação, clareza e confiabilidade interna dos itens do instrumento foram avaliadas por comitê de juízes multiprofissional pela plataforma web E-surv, obtendo-se média de concordância ≥0,91. A compreensão do instrumento pela população-alvo teve clareza adequada com média de 0,96.
Conclusão: O EmpoderACO poderá contribuir para qualificar o processo de comunicação entre profissionais e pacientes, melhorar a adesão ao tratamento e os resultados clínicos, podendo ser replicado nos serviços de saúde.
Conflict of interest statement
Potencial conflito de interesse
Não há conflito com o presente artigo.
Figures




Comment in
-
Use of Warfarin in Oral Anticoagulation Therapy: Challenges and EmpoderACO Strategy for Promoting Patient Empowerment in Self-Care.Arq Bras Cardiol. 2023 Jun;120(6):e20230335. doi: 10.36660/abc.20230335. Arq Bras Cardiol. 2023. PMID: 37403874 Free PMC article. English, Portuguese. No abstract available.
Similar articles
-
Patient satisfaction after conversion from warfarin to direct oral anticoagulants for patients on extended duration of anticoagulation for venous thromboembolism - The SWAN Study.PLoS One. 2020 Jun 4;15(6):e0234048. doi: 10.1371/journal.pone.0234048. eCollection 2020. PLoS One. 2020. PMID: 32497116 Free PMC article.
-
Validation of knowledge and adherence assessment tools among patients on warfarin therapy in a Saudi hospital anticoagulant clinic.Int J Clin Pharm. 2018 Feb;40(1):56-66. doi: 10.1007/s11096-017-0569-5. Epub 2017 Nov 30. Int J Clin Pharm. 2018. PMID: 29189976
-
Development and validation of an instrument to determine patient knowledge: the oral anticoagulation knowledge test.Ann Pharmacother. 2006 Apr;40(4):633-8. doi: 10.1345/aph.1G562. Epub 2006 Mar 21. Ann Pharmacother. 2006. PMID: 16551766
-
Anticoagulation patient self-monitoring in the United States: considerations for clinical practice adoption.Pharmacotherapy. 2011 Dec;31(12):1161-74. doi: 10.1592/phco.31.12.1161. Pharmacotherapy. 2011. PMID: 22122179 Review.
-
[Self testing and self management of oral anticoagulants with warfarin].Harefuah. 2003 Sep;142(8-9):621-3, 645, 644. Harefuah. 2003. PMID: 14518167 Review. Hebrew.
Cited by
-
Use of Warfarin in Oral Anticoagulation Therapy: Challenges and EmpoderACO Strategy for Promoting Patient Empowerment in Self-Care.Arq Bras Cardiol. 2023 Jun;120(6):e20230335. doi: 10.36660/abc.20230335. Arq Bras Cardiol. 2023. PMID: 37403874 Free PMC article. English, Portuguese. No abstract available.
References
-
- Ageno W, Gallus AS, Wittkowsky A, Crowther M, Hylek EM, Palareti G. Oral Anticoagulant Therapy: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines. Chest. 2012;141(2) Suppl:e44S–e88S. doi: 10.1378/chest.11-2292. - DOI - PMC - PubMed
-
- Brasil. Ministério da Saúde. Secretaria de Ciência, Tecnologia e Insumos Estratégicos. Departamento de Assistência Farmacêutica e Insumos Estratégicos . Formulário Terapêutico Nacional 2010: Rename 2010. Brasília: Ministério da Saúde; 2010.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical